Pathogenesis of Liver Fibrosis
The DOI matches its Crossref record; 220 of the 222 references it cites were found in a registry or an index, and 2 are not checked yet.
Abstract
Liver fibrosis is a major cause of morbidity and mortality worldwide due to chronic viral hepatitis and, more recently, from fatty liver disease associated with obesity. Hepatic stellate cell activation represents a critical event in fibrosis because these cells become the primary source of extracellular matrix in liver upon injury. Use of cell-culture and animal models has expanded our understanding of the mechanisms underlying stellate cell activation and has shed new light on genetic regulation, the contribution of immune signaling, and the potential reversibility of the disease. As pathways of fibrogenesis are increasingly clarified, the key challenge will be translating new advances into the development of antifibrotic therapies for patients with chronic liver disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“STAT3, a member of the STATs family, is a key transcriptional mediator of cellular processes [43, 44].”
From Saikosaponin b1 Attenuates Liver Fibrosis by Blocking STAT3/Gli1 Interaction and Inducing Gli1 Degradation (2025) · cites this paper as [43]
In the citing paper
“they may also derive from portal fibroblasts, bone marrow-derived cells, circulating fibrocytes, [7] and by the controversially discussed epithelial-tomesenchymal (EMT) [8,9] or endothelial-to-mesenchymal (EndoTM) transition.[10,11]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [7]
Citations
Cites
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El–Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,415
Origins and Mechanisms of miRNAs and siRNAs
Carthew, R. W., & Sontheimer, E. J. (2009) · Cell · doi:10.1016/j.cell.2009.01.035 · Cited by 5,018
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842
Self-citationMany roads to maturity: microRNA biogenesis pathways and their regulation
Winter, J., Jung, S., Keller, S., Gregory, R. I., & Diederichs, S. (2009) · Nature Cell Biology · doi:10.1038/ncb0309-228 · Cited by 2,656
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320530 · Cited by 2,649
Mechanisms of Hepatic Fibrogenesis
Friedman, S. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.003 · Cited by 2,634
Self-citationEndothelial-to-mesenchymal transition contributes to cardiac fibrosis
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,222
Bendelac, A., Savage, P. B., & Teyton, L. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141711 · Cited by 2,155
Research works printed but not linked: 15
- 10.1172/jci200112373 · DOI · Paper page
- 10.1055/s-2001-17556 · DOI · Paper page
- Stupack DG., 2007, Oncology, 21, 6
- Hehlgans S, 2007, Biochim. Biophys. Acta, 1775, 163
- Omenetti A, 2008, J. Clin. Investig., 118, 3331
- Pinzani M, 1996, Am. J. Pathol., 148, 785
- Sims DE., 1991, Can. J. Cardiol., 7, 431
- Thimgan MS, 1999, Am. J. Physiol., 277, G137
- 10.1136/gut.2005.088690 · DOI · Paper page
- Gao B., 2005, Cell Mol. Immunol., 2, 92
- Anania FA, 1995, Hepatology, 21, 1640
- Connolly MK, 2009, J. Clin. Investig., 119, 3213
- Seki E, 2009, J. Clin. Investig., 119, 1858
- McCrudden R, 2000, Histol. Histopathol., 15, 1159
- 10.1002/hep.23046 · DOI · Paper page
Cited by
Items 101–200 of 1,007
Zhang, F., Zhang, Z., Chen, L., Kong, D., Zhang, X., Lu, C., Lu, Y., & Zheng, S. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12286 · Cited by 135
Wong, J. S. L., Kwok, G. G. W., Tang, V., Li, B. C. W., Leung, R., Chiu, J., Ma, K. W., She, W. H., Tsang, J., Lo, C. M., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001945 · Cited by 142
Regulation of wound healing and organ fibrosis by toll-like receptors
Huebener, P., & Schwabe, R. F. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.11.017 · Cited by 140
Wang, M., Gong, Q., Zhang, J., Chen, L., Zhang, Z., Lu, L., Yu, D., Han, Y., Zhang, D., Chen, P., et al. (2017) · Scientific Reports · doi:10.1038/srep43446 · Cited by 126
Zhang, D., Lu, Y., Zhang, Q. Y., Liu, L., Li, S., Yao, Y., Jiang, J., Liu, G. L., & Liu, Q. (2015) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2015.09.041 · Cited by 139
Xiang, D., Zou, J., Zhu, X., Chen, X., Luo, J., Kong, L., & Zhang, H. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153294 · Cited by 137
Zhang, Z., Zha, Y., Hu, W., Huang, Z., Gao, Z., Zang, Y., Chen, J., Dong, L., & Zhang, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.517953 · Cited by 128
The controversial role of mast cells in fibrosis
Bradding, P., & Pejler, G. (2018) · Immunological Reviews · doi:10.1111/imr.12626 · Cited by 129
Meng, D., Li, Z., Wang, G., Ling, L., Wu, Y., & Zhang, C. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.005 · Cited by 128
Chen, L., Yao, X., Yao, H., Ji, Q., Ding, G., & Liu, X. (2020) · The FASEB Journal · doi:10.1096/fj.201902307rrr · Cited by 131
Coagulation and coagulation signalling in fibrosis
Mercer, P. F., & Chambers, R. C. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.12.013 · Cited by 131
Jalan, R., Chiara, F. D., Vairappan, B., Andreola, F., Khetan, V. U., Malagó, M., Pinzani, M., Mookerjee, R. P., & Rombouts, K. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.019 · Cited by 130
CD8+ T cells regulate liver injury in obesity-related nonalcoholic fatty liver disease
Breuer, D. A., Pacheco, M. C., Washington, M. K., Montgomery, S. A., Hasty, A. H., & Kennedy, A. J. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00040.2019 · Cited by 113
Hai, Y., Zhang, Y., Liang, Y., Ma, X., Qi, X., Xiao, J., Xue, W., Luo, Y., & Yue, T. (2020) · Food Frontiers · doi:10.1002/fft2.50 · Cited by 129
Liu, M., Xu, Y., Han, X., Yin, L., Xu, L., Qi, Y., Zhao, Y., Liu, K., & Peng, J. (2015) · Scientific Reports · doi:10.1038/srep18038 · Cited by 117
Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease
Armandi, A., Rosso, C., Caviglia, G. P., & Bugianesi, E. (2021) · Metabolites · doi:10.3390/metabo11030155 · Cited by 126
Sun, H. Q., Zhang, J., Zhang, H., Zou, Z., Wang, F. S., & Jia, J. (2012) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2011.01561.x · Cited by 126
Poly (ADP-Ribose) Polymerase-1 Is a Key Mediator of Liver Inflammation and Fibrosis
Mukhopadhyay, P., Rajesh, M., Cao, Z., Horváth, B., Park, O., Wang, H., Erdelyi, K., Holovac, E., Wang, Y., Liaudet, L., et al. (2014) · Hepatology · doi:10.1002/hep.26763 · Cited by 125
Kimura, K., Ikoma, A., Shibakawa, M., Shimoda, S., Harada, K., Saio, M., Imamura, J., Osawa, Y., Kimura, M., Nishikawa, K., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.08.016 · Cited by 112
Chung, S. I., Moon, H., Ju, H.-L., Cho, K. J., Kim, D. Y., Han, K.-H., Eun, J. W., Nam, S. W., Ribback, S., Dombrowski, F., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.007 · Cited by 117
Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C
Simon, T. G., King, L. Y., Zheng, H., & Chung, R. T. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.08.013 · Cited by 114
Cheng, Q., Li, C., Yang, C.-F., Zhong, Y.-J., Wu, D., Shi, L., Chen, L., Li, Y.-W., & Li, L. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.12.006 · Cited by 122
Wu, Y., Liu, X., Zhou, Q. Y., Huang, C., Meng, X., Xu, F., & Li, J. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.09.028 · Cited by 121
Pathogenesis of Accelerated Fibrosis in HIV/HCV Co-infection
Lin, W., Weinberg, E. M., & Chung, R. T. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis926 · Cited by 119
Stewart, R. K., Dangi, A., Huang, C., Murase, N., Kimura, S., Stolz, D. B., Wilson, G. C., Lentsch, A. B., & Gandhi, C. R. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.09.013 · Cited by 119
“The role of activated HSCs in hepatic fibrosis and cirrhosis has been established [5,33].”
Zhao, J., Tang, N., Wu, K., Dai, W., Ye, C., Shi, J., Zhang, J., Ning, B., Zeng, X., & Lin, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108005 · Cited by 105
Yang, F., Luo, L., Zhu, Z., Zhou, X., Wang, Y., Xue, J., Zhang, J., Cai, X., Chen, Z.-L., Ma, Q., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00929 · Cited by 116
Mancarella, S., Cigliano, A., Chieti, A., Giannelli, G., & Dituri, F. (2019) · Seminars in Liver Disease · doi:10.1055/s-0038-1676121 · Cited by 115
Functional Immune Anatomy of the Liver—As an Allograft
Demetris, A. J., Bellamy, C. O. C., Gandhi, C. R., Prost, S., Nakanuma, Y., & Stolz, D. B. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13749 · Cited by 115
Li, J.-P., Gao, Y., Chu, S., Zhang, Z., Xia, C., Mou, Z., Song, X., He, W., Guo, X., & Chen, N. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.41 · Cited by 115
Molecular Mechanisms of Liver Fibrosis in HIV/HCV Coinfection
Mastroianni, C. M., Lichtner, M., Mascia, C., Zuccalà, P., & Vullo, V. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15069184 · Cited by 115
Animal and Organoid Models of Liver Fibrosis
Bao, Y., Wang, L., Pan, H., Zhang, T.-R., Chen, Y., Xu, S.-J., Mao, X., & Li, S.-W. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.666138 · Cited by 120
“The repair and healing processes of liver injury can be accompanied by the development of liver fibrosis, and if the factors underlying such injury are not addressed, the process of fibrosis continues, eventually leading to cirrhosis (Hernandez-Gea and Friedman, 2011; Parola and Pinzani, 2019).”
BackgroundCirrhotic portal hypertension: From pathophysiology to novel therapeutics
Gunarathne, L. S., Rajapaksha, H., Shackel, N., Angus, P. W., & Herath, C. B. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i40.6111 · Cited by 113
Wei, L., Chen, Q., Guo, A., Fan, J., Wang, R., & Zhang, H. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.04.016 · Cited by 106
Hsu, D. C., & Sereti, I. (2016) · Drugs · doi:10.1007/s40265-016-0546-7 · Cited by 112
Targeted Drug Delivery to Hepatic Stellate Cells for the Treatment of Liver Fibrosis
Chen, Z., Jain, A., Liu, H., Zhao, Z., & Cheng, K. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.256156 · Cited by 112
“After activation, quiescent HSCs migrate to the injury site, differentiate into myofibroblasts, and secrete large amounts of ECM as well as proinflammatory cytokines (Hernandez-Gea and Friedman, 2011).”
BackgroundExtracellular matrix-penetrating nanodrill micelles for liver fibrosis therapy
Fan, Q.-Q., Zhang, C.-L., Qiao, J.-B., Cui, P.-F., Xing, L., Oh, Y.-K., & Jiang, H.-L. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2019.119616 · Cited by 111
Intracellular Glutathione Depletion by Oridonin Leads to Apoptosis in Hepatic Stellate Cells
Kuo, L.-M., Kuo, C.-Y., Lin, C.-Y., Hung, M.-F., Shen, J.-J., & Hwang, T.-L. (2014) · Molecules · doi:10.3390/molecules19033327 · Cited by 110
Barcena-Varela, M., Paish, H., Alvarez, L., Uriarte, I., Latasa, M. U., Santamaria, E., Recalde, M., Garate, M., Claveria, A., Colyn, L., et al. (2021) · Gut · doi:10.1136/gutjnl-2019-320205 · Cited by 93
Yang, Y. J., Kim, B., Park, Y., Koo, S. I., & Lee, J. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.10.014 · Cited by 110
Chen, Q., Zhang, H., Cao, Y., Li, Y., Sun, S., Zhang, J., & Zhang, G. (2017) · Drug Design, Development and Therapy · doi:10.2147/dddt.s137507 · Cited by 107
Zhao, P., & Saltiel, A. R. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.011356 · Cited by 109
Thyroid hormones inhibit TGF-β signaling and attenuate fibrotic responses
Alonso-Merino, E., Martín Orozco, R., Ruíz-Llorente, L., Martínez-Iglesias, O. A., Velasco-Martín, J. P., Montero-Pedrazuela, A., Fanjul-Rodríguez, L., Contreras-Jurado, C., Regadera, J., & Aranda, A. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1506113113 · Cited by 108
The Roles of Neutrophils in the Pathogenesis of Liver Diseases
Tang, J., Yan, Z.-J., Feng, Q., Yu, L., & Wang, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.625472 · Cited by 109
“Activation of hepatic stellate cells (HSCs) that transdifferentiate from vitamin A–storing pericyte-like cells to α-SMA-positive, collagen-producing myofibroblasts is now well-established as the central driver of fibrosis (76, 77).”
BackgroundBansal, R., van Baarlen, J., Storm, G., & Prakash, J. (2015) · Scientific Reports · doi:10.1038/srep18272 · Cited by 107
Cellular basis of hepatic fibrosis and its role in inflammation and cancer
Kocabayoglu, P. (2013) · Frontiers in Bioscience · doi:10.2741/s368 · Cited by 100
Self-citationMatsumoto, Y., Itami, S., Kuroda, M., Yoshizato, K., Kawada, N., & Murakami, Y. (2016) · Molecular Therapy · doi:10.1038/mt.2016.127 · Cited by 107
Kim, K. M., Han, C. Y., Kim, J. Y., Cho, S. S., Kim, Y. S., Koo, J. H., Lee, J. M., Lim, S., Kang, K. W., Js, K., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.10.011 · Cited by 107
Wang, S., Chen, L., Shi, X., Wang, Y., & Xu, S. (2023) · Environmental Pollution · doi:10.1016/j.envpol.2023.121388 · Cited by 107
Alcohol directly stimulates epigenetic modifications in hepatic stellate cells
Page, A., Paoli, P. P., Hill, S. J., Howarth, R., Wu, R., Kweon, S.-M., French, J., White, S., Tsukamoto, H., Mann, D. A., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.09.033 · Cited by 95
p66Shc Contributes to Liver Fibrosis through the Regulation of Mitochondrial Reactive Oxygen Species
Zhao, Y., Wang, Z., Feng, D., Zhao, H., Lin, M., Hu, Y. W., Zhang, N., Lv, L., Gao, Z., Zhai, X., et al. (2019) · Theranostics · doi:10.7150/thno.29620 · Cited by 106
Kuo, C., Chiu, V. J.-Y., Hsieh, P., Chun-Yen, H., Huang, S.-T. J., Tzeng, I., Tsai, F., Chen, M., Liu, C.-T., & Chen, Y.-R. (2020) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2020.07.014 · Cited by 106
Gender Differences in Nonalcoholic Fatty Liver Disease
Mahtab, M. A., Ghosh, J., Bhatia, S. J., Nagral, A. S., Bangar, M., Menezes, S. B., Butt, N., Manchanayake, J., & Singh, S. P. (2022) · Euroasian Journal of Hepato-Gastroenterology · doi:10.5005/jp-journals-10018-1370 · Cited by 108
Eissa, L. A., Kenawy, H. I., El-Karef, A. A., Elsherbiny, N. M., & El-Mihi, K. A. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.08.016 · Cited by 105
The innate immune receptor TREM-1 promotes liver injury and fibrosis
Nguyen-Lefebvre, A. T., Ajith, A., Portik-Dobos, V., Horuzsko, D. D., Arbab, A. S., Dzutsev, A., Sadek, R., Trinchieri, G., & Horuzsko, A. (2018) · Journal of Clinical Investigation · doi:10.1172/jci98156 · Cited by 104
“Hepatic fibrosis is the consequence of liver damage produced by chronic infectious hepatitis, alcohol, or chemical insults (1-4).”
Matrix Metalloproteinases in Non-Neoplastic Disorders
Tokito, A., & Jougasaki, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071178 · Cited by 105
Meissner, E. G., McLaughlin, M., Matthews, L., Gharib, A. M., Wood, B. J., Levy, E., Sinkus, R., Virtaneva, K., Sturdevant, D., Martens, C., et al. (2016) · Liver International · doi:10.1111/liv.13177 · Cited by 94
Matrix mechanics and regulation of the fibroblast phenotype
Hinz, B. (2013) · Periodontology 2000 · doi:10.1111/prd.12030 · Cited by 90
Nanotechnology applications for the therapy of liver fibrosis
Giannitrapani, L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i23.7242 · Cited by 93
Wang, Q., Dai, X., Yang, W., Wang, H., Zhao, H., Yang, F., Yang, Y., Li, J., & Lv, X. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.02.012 · Cited by 102
Paquissi, F. C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01195 · Cited by 93
Food components with antifibrotic activity and implications in prevention of liver disease
Bae, M., Park, Y., & Lee, J. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.11.003 · Cited by 101
Regulatory T cells (Tregs) in liver fibrosis
Wu, K.-J., Qian, Q.-F., Zhou, J.-R., Sun, D.-L., Duan, Y.-F., Zhu, X., Sartorius, K., & Lu, Y.-J. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01347-8 · Cited by 83
“In patients suffering from chronic liver injury, progression to the end stage usually takes 20 to 40 years depending on whether both environmental and genetic elements are causal factors [1].”
BackgroundVirus induced inflammation and cancer development
Read, S. A., & Douglas, M. W. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.07.030 · Cited by 103
“Inflammation and leukocyte infiltration trigger activation of resident hepatic stellate cells, making them responsive to transforming growth factor b (TGF-b) [40,41].”
BackgroundEndothelium-mediated contributions to fibrosis
Sun, X., Nkennor, B., Mastikhina, O., Soon, K., & Nunes, S. S. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.10.015 · Cited by 100
Heme Oxygenase, Inflammation, and Fibrosis: The Good, the Bad, and the Ugly?
Lundvig, D. M. S., Immenschuh, S., & Wagener, F. A. D. T. G. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00081 · Cited by 85
The Many Roles of Cell Adhesion Molecules in Hepatic Fibrosis
Hintermann, E., & Christen, U. (2019) · Cells · doi:10.3390/cells8121503 · Cited by 88
SECs (Sinusoidal Endothelial Cells), Liver Microenvironment, and Fibrosis
Natarajan, V., Harris, E. N., & Kidambi, S. (2017) · BioMed Research International · doi:10.1155/2017/4097205 · Cited by 84
Bai, T., Yang, Y., Wu, Y., Jiang, S., Lee, J. J., Lian, L., & Nan, J. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.02.006 · Cited by 98
Helium Generated Cold Plasma Finely Regulates Activation of Human Fibroblast-Like Primary Cells
Brun, P., Pathak, S., Castagliuolo, I., Palù, G., Brun, P., Zuin, M., Cavazzana, R., & Martines, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104397 · Cited by 98
Nishitsuji, H., Funami, K., Shimizu, Y., Ujino, S., Sugiyama, K., Seya, T., Takaku, H., & Shimotohno, K. (2013) · Journal of Virology · doi:10.1128/jvi.00974-13 · Cited by 88
Sutherland, J. J., Webster, Y., Willy, J. A., Searfoss, G. H., Goldstein, K. M., Irizarry, A. R., Hall, D. G., & Stevens, J. L. (2017) · The Pharmacogenomics Journal · doi:10.1038/tpj.2017.17 · Cited by 97
Extra- and Intra-Cellular Mechanisms of Hepatic Stellate Cell Activation
Yan, Y., Zeng, J., Xing, L., & Li, C. (2021) · Biomedicines · doi:10.3390/biomedicines9081014 · Cited by 96
“Hepatic stellate cell (HSC) activation represents a critical event in fibrosis [6,7].”
BackgroundmiR-106b-25/miR-17-92clusters: Polycistrons with oncogenic roles in hepatocellular carcinoma
Tan, W., Yang, L., Lim, S. G., & Tan, T. M. C. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i20.5962 · Cited by 96
Saidu, N. E. B., Bonini, C., Dickinson, A. M., Grce, M., Inngjerdingen, M., Koehl, U., Toubert, A., Zeiser, R., & Galimberti, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.578314 · Cited by 95
“In addition, other signaling pathways, such as MEK/ERK and phosphatidylinositol-3 kinase (PI3K)/Akt seem to be activated by TKs during hepatic stellate cells activation; this is the basis for employing TKIs in diseases such as liver fibrosis (72) Table 3.”
BackgroundAutophagy: A Multifaceted Partner in Liver Fibrosis
Mallat, A., Lodder, J., Teixeira-Clerc, F., Moreau, R., Codogno, P., & Lotersztajn, S. (2014) · BioMed Research International · doi:10.1155/2014/869390 · Cited by 93
Wu, J. H., Huang, J., Kuang, S., Chen, J., Li, M., Chen, B., Wang, J., Cheng, D., & Shuai, X. (2019) · Advanced Science · doi:10.1002/advs.201801809 · Cited by 94
Nie, Y., Liu, Q., Zhang, W., Wan, Y., Huang, C., & Zhu, X. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1972746 · Cited by 93
“In response to chronic injury, HSCs undergo activation, which is characterized by the loss of lipid droplets and the production of extracellular matrix (ECM) proteins.(2,21) Activated HSCs and cross-linked ECM lead to liver fibrosis and subsequent liver failure.”
BackgroundFang, L., Zhan, S., Huang, C. Z., Cheng, X., Lv, X., Si, H., & Li, J. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.08.009 · Cited by 93
“Hepatic stellate cells (HSCs) are the primary hepatic cell type responsible for excess deposition of ECM during fibrogenesis (Hernandez-Gea and Friedman, 2011).”
BackgroundLysophosphatidic acid-1-receptor targeting agents for fibrosis
Rancoule, C., Pradère, J.-P., Gonzalez, J., Klein, J., Valet, P., Bascands, J.-L., Schanstra, J. P., & Saulnier-Blache, J.-S. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.566864 · Cited by 84
Splicing regulator SLU7 is essential for maintaining liver homeostasis
Elizalde, M., Urtasun, R., Azkona, M., Latasa, M. U., Goñi, S., García-Irigoyen, O., Uriarte, I., Segura, V., Collantes, M., Di Scala, M., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74382 · Cited by 92
Li, X., Huai, Q., Zhu, C., Zhang, X., Xu, W., Dai, H., & Wang, H. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.07.009 · Cited by 77
Zhang, F., Kong, D., Lu, Y., & Zheng, S. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1046-x · Cited by 92
Song, J. H., Ge, Z., Yang, X., Luo, Q. F., Wang, C., You, H., Ge, T., Deng, Y., Lin, H., Cui, Y., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.10.021 · Cited by 93
Ganai, A. A., & Husain, M. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.11.022 · Cited by 91
LncRNA-MEG3 inhibits activation of hepatic stellate cells through SMO protein and miR-212
Yu, F., Geng, W., Dong, P., Huang, Z., & Zheng, J. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1068-x · Cited by 91
Sphingosine-1-phosphate: A Janus-faced mediator of fibrotic diseases
Schwalm, S. A., Pfeilschifter, J. M., & Huwiler, A. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.07.022 · Cited by 90
Regulation of Cellular Senescence by miR-34a in Alcoholic Liver Injury
Wan, Y., McDaniel, K. M., Wu, N., Ramos‐Lorenzo, S., Glaser, T., Venter, J. K., Francis, H., Kennedy, L. L., Sato, K., Zhou, T., et al. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.08.027 · Cited by 91
Hepatic Stellate Cells and Liver Fibrosis
Puche, J. E., Saiman, Y., & Friedman, S. L. (2013) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2013.tb00529.x · Cited by 89
“, sarcoidosis), and drug toxicity, among others (102).”
Self-citationQian, H., Deng, X., Huang, Z., Wei, J., Ding, C., Feng, R.-X., Zeng, X. Y., Chen, Y.-X., Ding, J., Qiu, L., et al. (2015) · Cell Research · doi:10.1038/cr.2015.84 · Cited by 90
Coffee and Caffeine Protect against Liver Injury Induced by Thioacetamide in Male Wistar Rats
Furtado, K. S., Prado, M. G., Aguiar e Silva, M. A., Dias, M. C., Rivelli, D. P., Rodrigues, M. A. M., & Barbisan, L. F. (2012) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2012.00903.x · Cited by 88
Caviglia, J. M., Yan, J., Jang, M. K., Gwak, G., Affò, S., Yu, L., Olinga, P., Friedman, R. A., Chen, X., & Schwabe, R. F. (2018) · Hepatology · doi:10.1002/hep.29627 · Cited by 89
Wan, J., Zhang, Y., Yang, D., Liang, Y., Yang, L., Hu, S., Liu, Z., Fang, Q., Tian, S., & Ding, Y. (2021) · Hepatology · doi:10.1002/hep.32068 · Cited by 88
An Overview of Hedgehog Signaling in Fibrosis
Hu, L., Lin, X., Lu, H., Chen, B., & Bai, Y. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.095141 · Cited by 90
Liver Injury and Disease Pathogenesis in Chronic Hepatitis C
Yamane, D., McGivern, D. R., Masaki, T., & Lemon, S. M. (2013) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-27340-7_11 · Cited by 88
Theron, A. J., Anderson, R., Rossouw, T. M., & Steel, H. C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01461 · Cited by 89
Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patients
Sun, X., Mei, J., Lin, W., Yang, Z., Peng, W. J., Chen, J., Zhang, Y., Xu, L., & Chen, M. (2021) · BMC Cancer · doi:10.1186/s12885-021-08428-w · Cited by 87
Harris, T. R., Bettaieb, A., Kodani, S. D., Dong, H., Myers, R., Chiamvimonvat, N., Haj, F. G., & Hammock, B. D. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.03.022 · Cited by 87
Epithelial-mesenchymal transition in chronic liver disease: fibrogenesis or escape from death?
Pinzani, M. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.02.001 · Cited by 86
Liu, J., Kong, D., Qiu, J., Xie, Y., Lu, Z., Zhou, C., Liu, X., Zhang, R., & Wang, Y. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14831 · Cited by 86
“Liver fibrosis is characterized by excessive accumulation of extracellular matrix (ECM) and hepatic stellate cells (HSCs) that are undergoing myofibroblast transition, which can be identified by the expression of α-smooth muscle actin (α-SMA; Hernandez-Gea & Friedman, 2011).”
Background
Metadata
- Authors
- Hernandez-Gea, V., & Friedman, S. L.
- Affiliations
- Division of Liver Diseases, Mount Sinai School of Medicine, New York, New York 10029;
- Icahn School of Medicine at Mount Sinai (US)
- ORCID
- Friedman, Scott L.
- Venue
- Annual Review of Pathology: Mechanisms of Disease
- Publisher
- Annual Reviews
- Published
- 2011-02-28
- Volume
- 6
- Issue
- 1
- Pages
- 425-456
- ISSN
- 1553-4006 (ISSN-L)
- 1553-4014
- OpenAlex
- W2142988890
- Cited by
- 1,809
- References
- 220
- Citations by year
- 2026: 81 · 2025: 123 · 2024: 121 · 2023: 112 · 2022: 148 · 2021: 174 · 2020: 145 · 2019: 119 · 2018: 117 · 2017: 131 · 2016: 136 · 2015: 124 · 2014: 97 · 2013: 76 · 2012: 67
- FWCI
- 10.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annual Review of Pathology Mechanisms of Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- liver fibrosis, hepatic stellate cell activation, extracellular matrix, chronic viral hepatitis, hepatic steatosis, obesity, immune signaling, genetic control, fibrosis reversibility, antifibrotic therapy, chronic liver disease
- MeSH terms
- Humans, Liver, Liver Cirrhosis, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.